Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team Gallery Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of teamChloe Atkinson2024-04-08T14:08:54+01:0026/03/2024|Read More
SBC wins Best Performing Facilities Provider of the Year Category at One Nucleus’ Awards Gallery SBC wins Best Performing Facilities Provider of the Year Category at One Nucleus’ AwardsChloe Atkinson2024-04-02T22:39:35+01:0022/03/2024|Read More
£17.9 million to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and keep UK as a location of choice for research Gallery £17.9 million to enhance the UK environment for advanced therapy medicinal product (ATMP) clinical trials and keep UK as a location of choice for researchChloe Atkinson2024-04-02T22:39:45+01:0021/03/2024|Read More
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates Gallery Autolus Therapeutics Reports Full Year 2023 Financial Results and Business UpdatesChloe Atkinson2024-04-02T22:39:55+01:0014/03/2024|Read More
Eight Start-Ups Arrive for Catalyser 2024 Kick Off Gallery Eight Start-Ups Arrive for Catalyser 2024 Kick OffChloe Atkinson2024-04-02T22:40:05+01:0012/03/2024|Read More
Four inspiring female leaders discuss their career journeys for International Women’s Day 2024 at SBC Gallery Four inspiring female leaders discuss their career journeys for International Women’s Day 2024 at SBCChloe Atkinson2024-04-02T22:40:15+01:0008/03/2024|Read More
ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya Gallery ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and KenyaChloe Atkinson2024-04-02T22:40:36+01:0007/03/2024|Read More
GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myeloma Gallery GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myelomaChloe Atkinson2024-04-02T22:40:26+01:0007/03/2024|Read More
LifeArc joins £20m international project to develop novel cancer treatment for children Gallery LifeArc joins £20m international project to develop novel cancer treatment for childrenChloe Atkinson2024-04-02T22:40:57+01:0006/03/2024|Read More
ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) compared to daily oral therapy in individuals living with HIV who have adherence challenges Gallery ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) compared to daily oral therapy in individuals living with HIV who have adherence challengesChloe Atkinson2024-04-02T22:40:46+01:0006/03/2024|Read More